These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25151557)
1. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance. Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557 [TBL] [Abstract][Full Text] [Related]
2. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC). Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831 [TBL] [Abstract][Full Text] [Related]
4. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202 [TBL] [Abstract][Full Text] [Related]
5. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Silsirivanit A; Araki N; Wongkham C; Pairojkul C; Narimatsu Y; Kuwahara K; Narimatsu H; Wongkham S; Sakaguchi N Cancer; 2011 Aug; 117(15):3393-403. PubMed ID: 21287531 [TBL] [Abstract][Full Text] [Related]
6. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171 [TBL] [Abstract][Full Text] [Related]
7. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505 [TBL] [Abstract][Full Text] [Related]
8. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures. Lempinen M; Isoniemi H; Mäkisalo H; Nordin A; Halme L; Arola J; Höckerstedt K; Stenman UH J Hepatol; 2007 Nov; 47(5):677-83. PubMed ID: 17640760 [TBL] [Abstract][Full Text] [Related]
9. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Wongkham S; Sheehan JK; Boonla C; Patrakitkomjorn S; Howard M; Kirkham S; Sripa B; Wongkham C; Bhudhisawasdi V Cancer Lett; 2003 May; 195(1):93-9. PubMed ID: 12767517 [TBL] [Abstract][Full Text] [Related]
10. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study. Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272 [TBL] [Abstract][Full Text] [Related]
11. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130 [TBL] [Abstract][Full Text] [Related]
12. The value of biliary fibronectin for diagnosis of cholangiocarcinoma. Chen CY; Lin XZ; Tsao HC; Shiesh SC Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951 [TBL] [Abstract][Full Text] [Related]
13. [Sivelestat sodium inhibits neutrophil elastase to regulate intrahepatic biliary mucin 5AC expression]. Gu X; Ye H; Xu C; Lin Z; Li J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):609-615. PubMed ID: 38991960 [TBL] [Abstract][Full Text] [Related]
14. Plasma Bile Acid Profiling and Modulation of Secreted Mucin 5AC in Cholangiocarcinoma. Danese E; Lievens PM; Padoan A; Peserico D; Galavotti R; Negrini D; Gelati M; Conci S; Ruzzenente A; Salvagno GL; Lippi G Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628976 [TBL] [Abstract][Full Text] [Related]
15. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [TBL] [Abstract][Full Text] [Related]
16. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Beyazit Y; Purnak T; Suvak B; Kurt M; Sayilir A; Turhan T; Tas A; Torun S; Celik T; Ibis M; Haznedaroglu IC Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):644-9. PubMed ID: 21802387 [TBL] [Abstract][Full Text] [Related]
17. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma. Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173 [TBL] [Abstract][Full Text] [Related]
18. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis. Alvaro D; Macarri G; Mancino MG; Marzioni M; Bragazzi M; Onori P; Corradini SG; Invernizzi P; Franchitto A; Attili AF; Gaudio E; Benedetti A Ann Intern Med; 2007 Oct; 147(7):451-9. PubMed ID: 17909206 [TBL] [Abstract][Full Text] [Related]
19. Serum and bile biomarkers for cholangiocarcinoma. Alvaro D Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin. Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]